Other Species / Isoforms
  CHCHD3 (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T11-p
TASTRRVtFEADENE
Upstream
2 1
Kinase, in vitro:
  • PKACA (mouse)
Treatment
  • cAMP_analog
CHCHD3 (human) TTSTRRVtFEADENE T11-p
CHCHD3 (mouse) TASTRRVtFEADENE T11-p
CHCHD3 (rat) TASTRRVTFEADENE T11
S29-p
VVKGIRLsENVIDRM
Upstream
0 10
Treatment
  • insulin
CHCHD3 (human) VVKGIRLsENVIDrM S29-p
CHCHD3 (mouse) VVKGIRLsENVIDRM S29-p
CHCHD3 (rat) VVKGIRLSENVIDRM S29
R35
LsENVIDRMKESsPS
0 1
CHCHD3 (human) LsENVIDrMKESSPS R35-m1
CHCHD3 (mouse) LsENVIDRMKESsPS R35
CHCHD3 (rat) LSENVIDRMKESSPS R35
S40-p
IDRMKESsPSGSKSQ
0 2
CHCHD3 (human) IDrMKESSPSGSKsQ S40
CHCHD3 (mouse) IDRMKESsPSGSKSQ S40-p
CHCHD3 (rat) IDRMKESSPSGSKSQ S40
S46
SsPSGSKSQRyssVy
0 8
CHCHD3 (human) SSPSGSKsQRysGAy S46-p
CHCHD3 (mouse) SsPSGSKSQRyssVy S46
CHCHD3 (rat) SSPSGSKSQRYssVY S46
Y49-p
SGSKSQRyssVyGAs
Upstream
0 10
Treatment
  • long-term_potentiation
CHCHD3 (human) SGSKsQRysGAyGAs Y49-p
CHCHD3 (mouse) SGSKSQRyssVyGAs Y49-p
CHCHD3 (rat) SGSKSQRYssVYGAs Y49
S50-p
GSKSQRyssVyGAsV
0 42
CHCHD3 (human) GSKsQRysGAyGAsV S50-p
CHCHD3 (mouse) GSKSQRyssVyGAsV S50-p
CHCHD3 (rat) GSKSQRYssVYGAsV S50-p
S51-p
SKSQRyssVyGAsVs
Upstream
0 14
Treatment
  • insulin
  • long-term_potentiation
  • LY294002
CHCHD3 (human) SKsQRysGAyGAsVs G51
CHCHD3 (mouse) SKSQRyssVyGAsVs S51-p
CHCHD3 (rat) SKSQRYssVYGAsVS S51-p
Y53-p
SQRyssVyGAsVsDE
0 16
CHCHD3 (human) sQRysGAyGAsVsDE Y53-p
CHCHD3 (mouse) SQRyssVyGAsVsDE Y53-p
CHCHD3 (rat) SQRYssVYGAsVSDE Y53
S56-p
yssVyGAsVsDEDLk
0 7
CHCHD3 (human) ysGAyGAsVsDEELk S56-p
CHCHD3 (mouse) yssVyGAsVsDEDLk S56-p
CHCHD3 (rat) YssVYGAsVSDEELK S56-p
S58-p
sVyGAsVsDEDLkRR
0 12
CHCHD3 (human) GAyGAsVsDEELkRR S58-p
CHCHD3 (mouse) sVyGAsVsDEDLkRR S58-p
CHCHD3 (rat) sVYGAsVSDEELKRR S58
K63-ac
sVsDEDLkRRVAEEL
0 4
CHCHD3 (human) sVsDEELkRRVAEEL K63-ac
CHCHD3 (mouse) sVsDEDLkRRVAEEL K63-ac
CHCHD3 (rat) sVSDEELKRRVAEEL K63
K63-ub
sVsDEDLkRRVAEEL
0 11
CHCHD3 (human) sVsDEELkRRVAEEL K63-ub
CHCHD3 (mouse) sVsDEDLkRRVAEEL K63-ub
CHCHD3 (rat) sVSDEELKRRVAEEL K63
K76
ELALEQAKKESEHQR
0 4
CHCHD3 (human) ELALEQAkkEsEDQK K76-ub
CHCHD3 (mouse) ELALEQAKKESEHQR K76
CHCHD3 (rat) ELALEQAKMESENQR K76
K76-sc
ELALEQAkKESEHQR
0 1
CHCHD3 (human) ELALEQAkkEsEDQK K76-sc
CHCHD3 (mouse) ELALEQAkKESEHQR K76-sc
CHCHD3 (rat) ELALEQAKMESENQR K76
K77
LALEQAkKESEHQRR
0 1
CHCHD3 (human) LALEQAkkEsEDQKR K77-ub
CHCHD3 (mouse) LALEQAkKESEHQRR K77
CHCHD3 (rat) LALEQAKMESENQRR M77
S79
LEQAkKESEHQRRLK
0 1
CHCHD3 (human) LEQAkkEsEDQKRLK S79-p
CHCHD3 (mouse) LEQAkKESEHQRRLK S79
CHCHD3 (rat) LEQAKMESENQRRLK S79
S112-p
AVLRERIssEEERMK
Upstream
0 6
Treatment
  • insulin
CHCHD3 (human) AILRERICsEEERAK C112
CHCHD3 (mouse) AVLRERIssEEERMK S112-p
CHCHD3 (rat) AILQERISSEENRTK S112
S113-p
VLRERIssEEERMKA
Upstream
0 45
Treatment
  • insulin
CHCHD3 (human) ILRERICsEEERAKA S113-p
CHCHD3 (mouse) VLRERIssEEERMKA S113-p
CHCHD3 (rat) ILQERISSEENRTKV S113
Y141-p
MRKQDAFykEQLARL
0 10
CHCHD3 (human) LKKQDAFykEQLARL Y141-p
CHCHD3 (mouse) MRKQDAFykEQLARL Y141-p
CHCHD3 (rat) IRKQDAFYKEQLSRL Y141
K142-ac
RKQDAFykEQLARLE
0 2
CHCHD3 (human) KKQDAFykEQLARLE K142-ac
CHCHD3 (mouse) RKQDAFykEQLARLE K142-ac
CHCHD3 (rat) RKQDAFYKEQLSRLE K142
K142
RKQDAFyKEQLARLE
0 4
CHCHD3 (human) KKQDAFykEQLARLE K142-ub
CHCHD3 (mouse) RKQDAFyKEQLARLE K142
CHCHD3 (rat) RKQDAFYKEQLSRLE K142
K142-sc
RKQDAFykEQLARLE
0 1
CHCHD3 (human) KKQDAFyKEQLARLE K142
CHCHD3 (mouse) RKQDAFykEQLARLE K142-sc
CHCHD3 (rat) RKQDAFYKEQLSRLE K142
S152-p
LARLEERsSEFYkVT
0 1
CHCHD3 (human) LARLEERSSEFYRVT S152
CHCHD3 (mouse) LARLEERsSEFYkVT S152-p
CHCHD3 (rat) LSRLEERSSEFYKVT S152
K157-ac
ERsSEFYkVTTEEYQ
0 2
CHCHD3 (human) ERSSEFYRVTTEQYQ R157
CHCHD3 (mouse) ERsSEFYkVTTEEYQ K157-ac
CHCHD3 (rat) ERSSEFYKVTTEEYQ K157
K157-ub
ERsSEFYkVTTEEYQ
0 1
CHCHD3 (human) ERSSEFYRVTTEQYQ R157
CHCHD3 (mouse) ERsSEFYkVTTEEYQ K157-ub
CHCHD3 (rat) ERSSEFYKVTTEEYQ K157
K157-sc
ERsSEFYkVTTEEYQ
0 1
CHCHD3 (human) ERSSEFYRVTTEQYQ R157
CHCHD3 (mouse) ERsSEFYkVTTEEYQ K157-sc
CHCHD3 (rat) ERSSEFYKVTTEEYQ K157
K165-ac
VTTEEYQkAAEEVEA
0 2
CHCHD3 (human) VTTEQYQKAAEEVEA K165
CHCHD3 (mouse) VTTEEYQkAAEEVEA K165-ac
CHCHD3 (rat) VTTEEYQkAAEEVES K165-ac
K165
VTTEEYQKAAEEVEA
0 16
CHCHD3 (human) VTTEQYQkAAEEVEA K165-ub
CHCHD3 (mouse) VTTEEYQKAAEEVEA K165
CHCHD3 (rat) VTTEEYQKAAEEVES K165
K173-ac
AAEEVEAkFKRYEyH
0 3
CHCHD3 (human) AAEEVEAkFKRyEsH K173-ac
CHCHD3 (mouse) AAEEVEAkFKRYEyH K173-ac
CHCHD3 (rat) AAEEVESkFRRYEyH K173-ac
K173-ub
AAEEVEAkFKRYEyH
0 2
CHCHD3 (human) AAEEVEAkFKRyEsH K173-ub
CHCHD3 (mouse) AAEEVEAkFKRYEyH K173-ub
CHCHD3 (rat) AAEEVESKFRRYEyH K173
Y177
VEAkFKRYEyHPVCA
0 1
CHCHD3 (human) VEAkFKRyEsHPVCA Y177-p
CHCHD3 (mouse) VEAkFKRYEyHPVCA Y177
CHCHD3 (rat) VESkFRRYEyHPVCA Y177
Y179-p
AkFKRYEyHPVCADL
0 36
CHCHD3 (human) AkFKRyEsHPVCADL S179-p
CHCHD3 (mouse) AkFKRYEyHPVCADL Y179-p
CHCHD3 (rat) SkFRRYEyHPVCADL Y179-p
K189
VCADLQTKILQCYRQ
0 14
CHCHD3 (human) VCADLQAkILQCYRE K189-ub
CHCHD3 (mouse) VCADLQTKILQCYRQ K189
CHCHD3 (rat) VCADLQTKILQCYRQ K189
T198-p
LQCYRQNtQQTLsCs
0 4
CHCHD3 (human) LQCYRENtHQTLKCS T198-p
CHCHD3 (mouse) LQCYRQNtQQTLsCs T198-p
CHCHD3 (rat) LQCYRQNTQQTLSCS T198
S203-p
QNtQQTLsCsALASQ
0 1
CHCHD3 (human) ENtHQTLKCSALATQ K203
CHCHD3 (mouse) QNtQQTLsCsALASQ S203-p
CHCHD3 (rat) QNTQQTLSCSALANQ S203
S205-p
tQQTLsCsALASQYM
0 1
CHCHD3 (human) tHQTLKCSALATQYM S205
CHCHD3 (mouse) tQQTLsCsALASQYM S205-p
CHCHD3 (rat) TQQTLSCSALANQYM S205
K225
AKQSMLEKGG_____
0 1
CHCHD3 (human) AKQSMLEkGG_____ K225-ub
CHCHD3 (mouse) AKQSMLEKGG_____ K225
CHCHD3 (rat) AKQNMLEKGG_____ K225